Showing results (741-750 of 766) with videos related to
Sort By:
Pageof 77
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 11, 2013
CLCN7 and TCIRG1 mutations differentially affect bone matrix mineralization in osteopetrotic individualsFlorian Barvencik, Ingo Kurth, Till Koehne, et al.Human Molecular Genetics|October 3, 2015
Impaired bone remodeling and its correction by combination therapy in a mouse model of mucopolysaccharidosis-ISonja C Kuehn, Till Koehne, Kerstin Cornils, et al.Bone Research|November 11, 2021
The WNT1G177C mutation specifically affects skeletal integrity in a mouse model of osteogenesis imperfecta type XVNele Vollersen, Wenbo Zhao, Tim Rolvien, et al.Bone Research|January 28, 2022
Procalcitonin is expressed in osteoblasts and limits bone resorption through inhibition of macrophage migration during intermittent PTH treatmentAnke Baranowsky, Denise Jahn, Shan Jiang, et al.Clinical Genitourinary Cancer|October 4, 2016
Predicting Time From Metastasis to Overall Survival in Castration-Resistant Prostate Cancer: Results From SEARCHDaniel M Moreira, Lauren E Howard, Katharine N Sourbeer, et al.The Journal of Urology|December 3, 2014
Practice patterns and predictors of followup imaging after a negative bone scan in men with castration resistant prostate cancer: results from the SEARCH databaseKatharine N Sourbeer, Lauren E Howard, Daniel M Moreira, et al.Science Translational Medicine|November 9, 2018
Wnt1 is an Lrp5-independent bone-anabolic Wnt ligandJulia Luther, Timur Alexander Yorgan, Tim Rolvien, et al.Prostate Cancer and Prostatic Diseases|July 15, 2015
Predicting bone scan positivity in non-metastatic castration-resistant prostate cancerD M Moreira, L E Howard, K N Sourbeer, et al.International Journal of Radiation Oncology, Biology, Physics|February 28, 2003
Effect of age on biochemical disease-free outcome in patients with T1-T3 prostate cancer treated with definitive radiotherapy in an equal-access health care system: a radiation oncology report of the Department of Defense Center for Prostate Disease ResearchPeter A S Johnstone, Robert H Riffenburgh, Judd W Moul, et al.Prostate Cancer and Prostatic Diseases|August 12, 2024
Select black men are potential candidates for prostate hemi-ablation based on radical prostatectomy histopathology for intermediate-risk prostate cancer-a multicenter SEARCH cohort studySriram Deivasigamani, Eric S Adams, Shannon Stock, et al.Pageof 77